Medtronic (NYSE: MDT) Q2 2025 Earnings Call Nov 19, 2024, 8:00 a.m. ET ...

Presentation Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations at Medtronic Good morning. I'm Ryan ...

Dexcom, like its main glucose sensor rival Abbott, has expanded beyond its core focus on diabetes and moved into the health and wellness market. The company recently introduced an over-the-counter ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of $90.00. Don't Miss our Black Friday Offers ...

Suffice it to say, though, that assuming you have a Dexcom sensor for glucose monitoring, the Oura app will now be able to ingest that data for easy viewing and also show it in line with other ...

Oura and Dexcom are partnering on metabolic health — and they mean big business. Dexcom has invested $75 million into Oura to make the deal happen, valuing Oura at $5 billion. That works out to ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other high growth large ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura’s Series D funding round and brings the ...

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom. The strategic investment brings Oura’s valuation to more than $5 ...

Medical device company DexCom (NASDAQ: DXCM) specializes in the diabetes care space. DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet ...